Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The treatment of severe and active Crohn’s disease is currently based on immunosuppression, but also involves the management of nutrition, appropriate selection of patients for surgery, and maintenance of remission in the long term. Corticosteroids remain the drug of the first choice, particularly in the acute setting. However, there is evolving understanding of the role of other immunosuppressants and immune modifiers, as major concerns regarding side‐effects and efficacy of steroids in the medium to long‐term drive the search for alternatives.

More information Original publication

DOI

10.1046/j.1365-2036.2001.00963.x

Type

Journal article

Publisher

Wiley

Publication Date

2001-05-15T00:00:00+00:00

Volume

15

Pages

563 - 573

Total pages

10